1591 related articles for article (PubMed ID: 26633628)
1. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
2. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
3. Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes.
Mardinoglu A; Boren J; Smith U
Cell Metab; 2016 Jan; 23(1):10-2. PubMed ID: 26771114
[TBL] [Abstract][Full Text] [Related]
4. Metformin and gut microbiota: their interactions and their impact on diabetes.
Vallianou NG; Stratigou T; Tsagarakis S
Hormones (Athens); 2019 Jun; 18(2):141-144. PubMed ID: 30719628
[TBL] [Abstract][Full Text] [Related]
5. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
[TBL] [Abstract][Full Text] [Related]
6. Metformin: old friend, new ways of action-implication of the gut microbiome?
Rodriguez J; Hiel S; Delzenne NM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
[TBL] [Abstract][Full Text] [Related]
7. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
[TBL] [Abstract][Full Text] [Related]
8. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota: Antidiabetic drug treatment confounds gut dysbiosis associated with type 2 diabetes mellitus.
Holmes D
Nat Rev Endocrinol; 2016 Feb; 12(2):61. PubMed ID: 26668122
[No Abstract] [Full Text] [Related]
10. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
Brunkwall L; Orho-Melander M
Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
[TBL] [Abstract][Full Text] [Related]
11. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.
Zhang M; Feng R; Yang M; Qian C; Wang Z; Liu W; Ma J
BMJ Open Diabetes Res Care; 2019; 7(1):e000717. PubMed ID: 31641523
[TBL] [Abstract][Full Text] [Related]
13. Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations.
Van Syoc E; Nixon MP; Silverman JD; Luo Y; Gonzalez FJ; Elbere I; Klovins J; Patterson AD; Rogers CJ; Ganda E
mBio; 2024 Jun; 15(6):e0016924. PubMed ID: 38767350
[TBL] [Abstract][Full Text] [Related]
14. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
Pedersen C; Gallagher E; Horton F; Ellis RJ; Ijaz UZ; Wu H; Jaiyeola E; Diribe O; Duparc T; Cani PD; Gibson GR; Hinton P; Wright J; La Ragione R; Robertson MD
Br J Nutr; 2016 Dec; 116(11):1869-1877. PubMed ID: 27974055
[TBL] [Abstract][Full Text] [Related]
15. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of
Shin NR; Gu N; Choi HS; Kim H
Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E52-E61. PubMed ID: 31770016
[TBL] [Abstract][Full Text] [Related]
17. Considering gut microbiota in treatment of type 2 diabetes mellitus.
Adeshirlarijaney A; Gewirtz AT
Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
[TBL] [Abstract][Full Text] [Related]
18. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
Wu H; Esteve E; Tremaroli V; Khan MT; Caesar R; Mannerås-Holm L; Ståhlman M; Olsson LM; Serino M; Planas-Fèlix M; Xifra G; Mercader JM; Torrents D; Burcelin R; Ricart W; Perkins R; Fernàndez-Real JM; Bäckhed F
Nat Med; 2017 Jul; 23(7):850-858. PubMed ID: 28530702
[TBL] [Abstract][Full Text] [Related]
19. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes.
Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J
Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.
Elbere I; Orlovskis Z; Ansone L; Silamikelis I; Jagare L; Birzniece L; Megnis K; Leskovskis K; Vaska A; Turks M; Klavins K; Pirags V; Briviba M; Klovins J
Gut Microbes; 2024; 16(1):2361491. PubMed ID: 38868903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]